6-Methoxy-2-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
- $115 - $2668
- Product name: 6-Methoxy-2-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
- CAS: 1256359-95-1
- MF: C15H20BNO3
- MW: 273.14
- EINECS:-0
- MDL Number:MFCD16295111
- Synonyms:6-Methoxy-2-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;6-Methoxyindole-2-boronic acid, pinacol ester;6-Methoxy-1H-indole-2-boronic acid pinacol ester;1H-Indole, 6-methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;6-Methoxy-1H-indole-2-boronic acid picol ester
3 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- TRC
Package
- 50mg
- 250mg
- 1g
- ManufacturerAK Scientific
- Product numberX0454
- Product description6-Methoxyindole-2-boronicacidpinacolester
- Packaging250mg
- Price$344
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11314449
- Product description6-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 95+%
- Packaging1g
- Price$424
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM263478
- Product description6-Methoxyindole-2-boronicacid,pinacolester
- Packaging50mg
- Price$115
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | X0454 | 6-Methoxyindole-2-boronicacidpinacolester | 250mg | $344 | 2021-12-16 | Buy |
Crysdot | CD11314449 | 6-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 95+% | 1g | $424 | 2021-12-16 | Buy |
TRC | M263478 | 6-Methoxyindole-2-boronicacid,pinacolester | 50mg | $115 | 2021-12-16 | Buy |
Properties
Boiling point :430.7±25.0 °C(Predicted)
Density :1.13±0.1 g/cm3(Predicted)
pka :16.99±0.30(Predicted)
Density :1.13±0.1 g/cm3(Predicted)
pka :16.99±0.30(Predicted)
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|